Keith Dawson - Concepedia

Author

Keith Dawson

Emory University

Also Known As

K. Dawson, K. L. Dawson, K.L. Dawson, Keith Dawson, Keith L Dawson, Keith L. Dawson, Keith Lamont Dawson

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Emory University University of Iowa RTI Health Solutions University of Rochester Memorial Sloan Kettering Cancer Center

About

Keith Dawson is an author at Emory University specializing in cancer research, oncology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	122
2	Business	1	1	10
3	Education	1	1	10
4	Management	1	1	10
5	Epidemiology	1	1	96

Keith Dawson

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study Carla Casulo, Michelle Byrtek, Keith Dawson, Journal of Clinical Oncology	2015	818
Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS) Nina D. Wagner‐Johnston, Brian K. Link, Michelle Byrtek, Blood	2015	213
Examination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predominantly in community practices Ajay K. Nooka, Chadi Nabhan, Xiaolei Zhou, Annals of Oncology Lymphoid NeoplasiaNational Lymphocare StudyEpidemiologyMedicinePathology	2012	96
Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma‐related mortality in elderly follicular lymphoma in the United States Chadi Nabhan, Michelle Byrtek, Ashish Rai, British Journal of Haematology	2015	70
Outcomes following watchful waiting for stage <scp>II</scp>–<scp>IV</scp> follicular lymphoma patients in the modern era Loretta J. Nastoupil, Rajni Sinha, Michelle Byrtek, British Journal of Haematology	2016	61
The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United States Loretta J. Nastoupil, Rajni Sinha, Michelle Byrtek, Cancer	2014	34
Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study Carla Casulo, Bann‐Mo Day, Keith Dawson, Annals of Oncology Disease CharacteristicsLymphoid NeoplasiaFollicular LymphomaLymphatic DiseaseTreatment Patterns	2015	29
Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular lymphoma used in the United States Loretta J. Nastoupil, Rajni Sinha, Michelle Byrtek, Leukemia & lymphoma/Leukemia and lymphoma Frontline Rituximab-chemotherapy RegimensCox ModelsLymphoid NeoplasiaMedicineChemotherapy	2014	26
Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: Results of the National LymphoCare Study Peter Martin, Michelle Byrtek, Keith Dawson, Cancer	2013	23
Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United States Chadi Nabhan, Xiaolei Zhou, Bann‐Mo Day, American Journal of Hematology	2016	22

Page 1